In the medical literature, there are case reports that Harvoni improves symptoms in patients with PCT. However, this has never been systematically tested. Therefore, the purpose of this study is to assess whether Harvoni alone is an effective therapy of active PCT in patients with Chronic Hepatitis C
The study is evaluating the effectiveness of the hepatitis B vaccine in people infected with chronic hepatitis C. The study includes healthy volunteers (people without hepatitis C). The objective of the study is to compare the immune response of the hepatitis B vaccine people with hepatitis C vs. healthy volunteers.
Effects of Persistent Innate Immune Activation on Vaccine Efficacy
To read the entire clinical trial description, click here…